all news

Our partners are building great companies. We love to share their stories.

Wed, 27 Sep 2023 Business Wire

Kallyope Enters Phase 2 With First-in-class Oral Approach for the Treatment of Both Obesity and Type 2 Diabetes

Wed, 27 Sep 2023 India - PRNewswire

Ono Enters into a Drug Discovery Collaboration Agreement with Adimab to Discover Novel Antibody Drugs in the Oncology Field

Thu, 21 Sep 2023 BioSpace

Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel

Thu, 21 Sep 2023 businesswire.com

Endpoints News Announces the 2023 Winners of the Endpoints 11 Awards, Highlighting Biotech’s Most Promising Startups

Thu, 21 Sep 2023 PR Newswire

Brella™ 3-Minute SweatControl Patch Wins Prestigious Allure 2023 Best of Beauty Breakthrough Award

Tue, 19 Sep 2023 PR Newswire

Baxter Planning's predictive Service Supply Chain platform chosen by Roche Diagnostics Corporation for Service Supply Chain Optimization

Sat, 16 Sep 2023 GlobeNewswire

Neumora Therapeutics Announces Pricing of Initial Public Offering

Wed, 13 Sep 2023 Behavioral Health Business

Gen Z Women’s Health Provider Caraway Acquires Digital Group Therapy Platform Sesh

Wed, 13 Sep 2023 Dewpoint Therapeutics

Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI to Radically Accelerate the Discovery of Molecules Targetin

Thu, 7 Sep 2023 HIT Consultant

OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience

Wed, 6 Sep 2023 businesswire.com

KSQ Therapeutics and CTMC Announce Strategic Collaboration to Accelerate the Development of Novel Engineered Tumor Infiltrating Lymphocyte (

Thu, 31 Aug 2023 GlobeNewswire

Jnana Therapeutics Presents Additional Data from Phase 1a Clinical Study of JNT-517 at SSIEM Annual Symposium

Thu, 31 Aug 2023 PrNewsWire.AE

IFS to acquire Falkonry AI

Tue, 29 Aug 2023 businesswire.com

Teen Mental Health Study Demonstrates Positive User Engagement and Satisfaction With the BeMe Health Platform

Wed, 23 Aug 2023 Employee Benefit News

Wellthy launches teen helpline to help parents address mental health needs

Tue, 22 Aug 2023 Nutritional Outlook

ByHeart infant formula makes retail debut at Target locations nationwide

Mon, 21 Aug 2023 Lehigh Valley Business

ByHeart infant formula to be sold at Target stores nationally

Tue, 15 Aug 2023 prnewswire.com

Tausight® Announces Additional $6 Million in Financing

Mon, 14 Aug 2023 Cyclerion Therapeutics, Inc.

Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets | Cyclerion Therapeutics, Inc.

Wed, 9 Aug 2023 Sunbird Bio

Sunbird Bio Merges with Glympse Bio to Accelerate Development of Proprietary Protein-Based Diagnostic Technologies

Wed, 9 Aug 2023 BioSpace

Jnana Therapeutics Announces Dosing of First Participant in Phase 1b Clinical Trial of JNT-517 in Individuals with PKU | BioSpace

Tue, 8 Aug 2023 SiliconANGLE

Simon Data reels in $54M for its AI-powered customer data platform

Mon, 7 Aug 2023 businesswire.com

Ankyra Therapeutics Appoints Robert V. Tighe, an accomplished industry veteran, as Chief Scientific Officer

Thu, 27 Jul 2023 Duke-NUS Medical School

Newly-discovered antibodies can neutralize COVID-19 variants, potentially prevent future coronavirus outbreaks

Wed, 26 Jul 2023 businesswire.com

Arsenal Medical Announces Treatment of First Patient with NeoCast™

Wed, 19 Jul 2023 acsmedchem.org

Jnana Co-founder and Founding CSO Named to MEDI Hall of Fame

Wed, 19 Jul 2023 Phreesia

Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers | Phreesia

Wed, 19 Jul 2023 Neumora

Neumora Therapeutics Announces Initiation of Phase 3 Clinical Program for Navacaprant (NMRA-140) in Major Depressive Disorder - Neumora

Thu, 13 Jul 2023 KSQ Therapeutics

KSQ Therapeutics Enters Worldwide License Agreement with Roche for KSQ-4279, a Clinical-Stage USP1 Inhibitor for Cancer - KSQ Therapeutics

Tue, 11 Jul 2023 GlobeNewswire

Crossbow Therapeutics Launches with $80 Million in Series A Financing to Advance a Novel Class of Antibody Therapies That Mimic T-Cell Recep